Fibromuscular dysplasia (FMD) is a non-atheroslcerotic, systemic arteriopathy with excess burden on women. FMD may have varying manifestations, including hypertension, stroke and myocardial infarction, among others, depending on the arterial beds involved by arterial stenosis, aneurysm, dissection or tortuosity. Thus, the clinical diagnosis of FMD encompasses a spectrum of arterial dysplasia phenotypes, and these may be either sporadic or familial. Our proposed studies will test the hypothesis that this spectrum of FMD implicates a limited number of genes and pathways, and a combined analysis of many cases, covering familial, sporadic, pediatric and adult cases, using both genetic and gene expression data, is the best way to uncover recurrently affected genes or convergent pathways. This hypothesis will be tested in three Specific Aims.
Specific Aim 1 : We will conduct gene discovery analyses of FMD in a large clinical resource of diverse demographic and phenotypic characteristics, in adult and pediatric cases of FMD, using both case-control approaches as well as family-based analyses.
Specific Aim 2 : We will conduct follow-up studies of genes associated with FMD, including studies of RNA expression in FMD and control arterial tissues and replication experiments in additional, independent samples.
Specific Aim 3 : Using functional laboratory approaches, we will test the cellular and arterial function of identified genes and variants relevant for arterial remodeling and dysplasia. The analyses and experiments proposed in these Specific Aims will allow us to systematically uncover causal DNA variants underlying FMD and to expand our knowledge of molecular defects driving arterial dysplasia.

Public Health Relevance

Fibromuscular dysplasia (FMD) is an arterial disease that can cause stenosis (inward growth), aneurysm (outward growth), dissection (tearing), or tortuosity (abnormal bending) of blood vessels, leading to manifestations such as high blood pressure, stroke and heart attacks. FMD is estimated to occur in 1-4% of the U.S. population and most often afflicts young women (90%). This study will use genetic approaches to find new genes for FMD and laboratory experiments to understand the impact of the identified genes on gene expression in cells and the arterial function of the identified genes. The biologic insights from this study will be important for developing novel diagnostic and therapeutic strategies for FMD.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL139672-01
Application #
9425793
Study Section
Genetics of Health and Disease Study Section (GHD)
Program Officer
OH, Youngsuk
Project Start
2018-01-01
Project End
2021-12-31
Budget Start
2018-01-01
Budget End
2018-12-31
Support Year
1
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109